Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: A single institutional experience.
- Publication date
- 1 January 2015
- Publisher
- Impact Journals Ltd, 6211 Tipton House, Ste 6, Albany, Usa, Ny, 12203 (USA)